Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cellular Genomics, Inc.
Alliance signed to study kinase drug targets
January 14th, 2004
Cellular Genomics, Inc., (CGI), a chemical genetics-based biopharmaceutical company, announced that it has entered into a research collaboration with Eli Lilly and Company, under which CGI will apply its chemical genetics Analog Sensitive Kinase Allele (ASKA) technology to the study of kinase drug targets selected by Lilly. "We are extremely pleased that Lilly has chosen to collaborate with CGI to further enhance their kinase drug discovery programs," said Louis Matis, president and CEO of CGI. "This marks the fifth collaboration we have established with a major pharmaceutical or biotechnology company based on our patented chemical genetics technologies, demonstrating...
Source: Biotech Week (2004-01-14)
|
